瘦型非酒精性脂肪性肝病：并非那么良性的病症？ - Suppr

Lean NAFLD: A not so benign condition?

作者信息

VanWagner Lisa B, Armstrong Matthew J

机构信息

Division of Gastroenterology and Hepatology, Department of Medicine Northwestern University Feinberg School of Medicine Chicago IL.

Department of Preventive Medicine Northwestern University Feinberg School of Medicine Chicago IL.

出版信息

Hepatol Commun. 2018 Jan 16;2(1):5-8. doi: 10.1002/hep4.1143. eCollection 2018 Jan.

DOI:10.1002/hep4.1143

PMID:29404505

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5776877/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ed1/5776877/7c8f172580e5/HEP4-2-5-g001.jpg

相似文献

Lean NAFLD: A not so benign condition?

Hepatol Commun. 2018 Jan 16;2(1):5-8. doi: 10.1002/hep4.1143. eCollection 2018 Jan.

Non-alcoholic Fatty Liver Disease in Lean Subjects: Characteristics and Implications.

J Clin Transl Hepatol. 2017 Sep 28;5(3):216-223. doi: 10.14218/JCTH.2016.00068. Epub 2017 Jul 5.

Metabolic syndrome is not uncommon among lean non-alcoholic fatty liver disease patients as compared with those with obesity.

Indian J Gastroenterol. 2020 Feb;39(1):75-83. doi: 10.1007/s12664-020-01020-3. Epub 2020 Apr 20.

Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup.

Clin Transl Gastroenterol. 2019 May 22;10(5):1-8. doi: 10.14309/ctg.0000000000000042.

Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.

Lancet Gastroenterol Hepatol. 2020 Aug;5(8):739-752. doi: 10.1016/S2468-1253(20)30077-7. Epub 2020 May 12.

Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study.

Arch Iran Med. 2017 Apr;20(4):211-217.

Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long-term follow-up study.

Hepatol Commun. 2017 Nov 30;2(1):48-57. doi: 10.1002/hep4.1124. eCollection 2018 Jan.

Lean non-alcoholic fatty liver disease patients had comparable total caloric, carbohydrate, protein, fat, iron, sleep duration and overtime work as obese non-alcoholic fatty liver disease patients.

J Gastroenterol Hepatol. 2019 Jan;34(1):256-262. doi: 10.1111/jgh.14360. Epub 2018 Jul 16.

Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.

Scand J Gastroenterol. 2015 Mar;50(3):341-6. doi: 10.3109/00365521.2014.983160. Epub 2014 Dec 26.

Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease.

Aliment Pharmacol Ther. 2018 Jan;47(1):16-25. doi: 10.1111/apt.14401. Epub 2017 Oct 30.

引用本文的文献

Nonlinear relationship between body fat percentage and NAFLD mediated by METS-IR: threshold effects and subgroup differences.

Sci Rep. 2025 Jul 10;15(1):24917. doi: 10.1038/s41598-025-10765-w.

Non-linear relationship between the hepatic steatosis index and glycemic progression: evidence from a large-scale retrospective cohort study in a Chinese population.

BMC Gastroenterol. 2025 Jul 1;25(1):484. doi: 10.1186/s12876-025-04068-7.

Characterizing Nonalcoholic Fatty Liver Disease (NAFLD) in Lean Individuals at a Tertiary Care Hospital: A Cross-sectional Study.

Euroasian J Hepatogastroenterol. 2024 Jul-Dec;14(2):198-204. doi: 10.5005/jp-journals-10018-1452. Epub 2024 Dec 27.

Association between alanine aminotransferase to high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease: a retrospective cohort study in lean Chinese individuals.

Sci Rep. 2024 Mar 13;14(1):6056. doi: 10.1038/s41598-024-56555-8.

Non-alcoholic Steatohepatitis in Asians: Current Perspectives and Future Directions.

Cureus. 2023 Aug 2;15(8):e42852. doi: 10.7759/cureus.42852. eCollection 2023 Aug.

Amelioration of non-alcoholic fatty liver disease by targeting adhesion G protein-coupled receptor F1 ().

Elife. 2023 Aug 15;12:e85131. doi: 10.7554/eLife.85131.

Loss of hepatic PPARα in mice causes hypertension and cardiovascular disease.

Am J Physiol Regul Integr Comp Physiol. 2023 Jul 1;325(1):R81-R95. doi: 10.1152/ajpregu.00057.2023. Epub 2023 May 22.

Thermoneutral housing shapes hepatic inflammation and damage in mouse models of non-alcoholic fatty liver disease.

Front Immunol. 2023 Feb 17;14:1095132. doi: 10.3389/fimmu.2023.1095132. eCollection 2023.

Nutritional Genomics in Nonalcoholic Fatty Liver Disease.

Biomedicines. 2023 Jan 23;11(2):319. doi: 10.3390/biomedicines11020319.

Association Between Hypertension and New-Onset Non-Alcoholic Fatty Liver Disease in Chinese Non-Obese People: A Longitudinal Cohort Study.

Diabetes Metab Syndr Obes. 2023 Feb 8;16:345-363. doi: 10.2147/DMSO.S396011. eCollection 2023.

本文引用的文献

Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long-term follow-up study.

Hepatol Commun. 2017 Nov 30;2(1):48-57. doi: 10.1002/hep4.1124. eCollection 2018 Jan.

Body mass index trajectories in young adulthood predict non-alcoholic fatty liver disease in middle age: The CARDIA cohort study.

Liver Int. 2018 Apr;38(4):706-714. doi: 10.1111/liv.13603. Epub 2017 Oct 13.

New trends on obesity and NAFLD in Asia.

J Hepatol. 2017 Oct;67(4):862-873. doi: 10.1016/j.jhep.2017.06.003. Epub 2017 Jun 19.

Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.

Clin Gastroenterol Hepatol. 2017 Oct;15(10):1604-1611.e1. doi: 10.1016/j.cgh.2017.04.045. Epub 2017 May 26.

Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients.

Aliment Pharmacol Ther. 2017 Jul;46(2):85-95. doi: 10.1111/apt.14112. Epub 2017 May 2.

Waist/Hip Ratio Better Predicts Development of Severe Liver Disease Within 20 Years Than Body Mass Index: A Population-based Cohort Study.

Clin Gastroenterol Hepatol. 2017 Aug;15(8):1294-1301.e2. doi: 10.1016/j.cgh.2017.02.040. Epub 2017 Mar 22.

Genetic predisposition in nonalcoholic fatty liver disease.

Clin Mol Hepatol. 2017 Mar;23(1):1-12. doi: 10.3350/cmh.2016.0109. Epub 2017 Mar 9.

Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients.

Hepatology. 2017 Jan;65(1):54-64. doi: 10.1002/hep.28697. Epub 2016 Jul 25.

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Hepatology. 2016 Jul;64(1):73-84. doi: 10.1002/hep.28431. Epub 2016 Feb 22.

Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy.

Am J Gastroenterol. 2015 Sep;110(9):1306-14; quiz 1315. doi: 10.1038/ajg.2015.235. Epub 2015 Jul 28.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Lean NAFLD: A not so benign condition?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献